Unknown

Dataset Information

Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist.


ABSTRACT: The analysis aimed at identifying subject-specific characteristics (covariates) influencing exposure to daridorexant and quantification of covariate effects to determine clinical relevance. Data from 13 phase I, two phase II, and two phase III studies were pooled to develop a population pharmacokinetic model describing daridorexant concentration over time. Covariate effects were quantified based on model predictions. A two-compartment model with dose-dependent bioavailability, absorption lag time, linear absorption, and nonlinear elimination described the data best. Statistically significant covariates were food status on absorption (lag time and rate constant), time of drug administration (morning, bedtime) on absorption rate constant, lean body weight on central volume of distribution an

SUBMITTER: Krause A 

PROVIDER: S-EPMC9835129 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature